Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-232
Closed -$21K 201
2021
Q1
$21K Buy
232
+4
+2% +$375 ﹤0.01% 259
2020
Q4
$21K Sell
228
-4
-2% -$357 ﹤0.01% 242
2020
Q3
$24K Buy
232
+12
+5% +$1.25K ﹤0.01% 223
2020
Q2
$22K Buy
+220
New +$19.7K ﹤0.01% 205

Other funds holding DXCM

Sun Life Financial's DXCM Position: Q2 2021 in Review

Sun Life Financial sold out of DexCom (DXCM) in Q2 2021, closing a stake of 232 shares — an estimated $21K sold.

Sun Life Financial first reported a position in DXCM in Q2 2020 and held it in 4 quarters. The position peaked at $24K in Q3 2020. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Sun Life Financial reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Sun Life Financial sold 232 DexCom shares in Q2 2021, an estimated $21K.
  • Sun Life Financial first reported a position in DexCom in Q2 2020 and held it in 4 quarters.
  • Sun Life Financial's DexCom position peaked at $24K in Q3 2020.
  • 726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.